Fetal heart rate monitoring is a process of measuring and monitoring the conditions of heart rate and rhythm of the baby during labor and delivery using special equipment. Fetal heart rate monitoring is routinely used in gynecology and obstetrics. It is essential in fetus management majorly in intrapartum stage. During high-risk pregnancy, fetal heart rate monitoring reduces fetal or neonatal demise, and helps to prevent severe neonatal asphyxia and infantile cerebral palsy (CP) due to fetal hypoxia. In addition, it aids in detection and measurement of any change in the normal heart rate pattern during labor. Two types of techniques are majorly used for heart rate monitoring, which include internal fetal heart rate monitoring and external fetal heart rate monitoring. Moreover, two types of devices are valuable for monitoring of fetal heart rate, including Doppler ultrasound device and electronic fetal monitoring device.
The global fetal heart rate monitoring devices market is expected to witness significant growth during the forecast period, due to factors such as increase in birth rates & preterm births, active government and nongovernment initiatives to provide better maternal & fetal care, rise in technological advancements pertaining to these devices. For instance, few novel technologies for fetal heart monitoring are gaining significant foothold in the fetal monitoring market. However, high costs of fetal heart rate monitoring devices and stringent regulatory procedures guiding the use of these devices are anticipated to restrain the market growth. Conversely, rise in awareness has generated the need for newer and advanced devices for monitoring of fetal heart rate devices. Hence, this has led to the development of new senor-based technology for fetal heart rate monitoring, which is expected to provide remunerative opportunities for market expansion during the forecast period.
The fetal heart rate monitoring devices market is segmented on the basis of product type, device type, portability, method, end user, and region. Based on product, the market is divided into internal fetal heart rate monitoring and external fetal heart rate monitoring. By device type, it is bifurcated into Doppler ultrasound device and electronic fetal monitoring device. Depending on method, it is categorized into invasive and noninvasive. As per portability, it is fragmented into portable and non-portable. According to end user, it is fragmented into hospitals, clinics, and home. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, Spain, UK, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
Major players operating in the global fetal heart rate monitoring device market include Toshiba Corporation, Drägerwerk AG & Co. KGaA, Invacare Corporation., Smiths Group plc, American HomePatient., Johnson & Johnson, CooperSurgical, Inc., Sunray Medical Apparatus Co., Ltd., Bionet America, Inc., Trismed Co., Ltd., and Edan Instruments Inc.
KEY BENEFITS FOR STAKEHOLDERS
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global fetal heart rate monitoring devices market is provided.
- Region-wise and country-wise market conditions are comprehensively analyzed in this report.
- The projections in this report are made by analyzing the current fetal heart rate monitoring devices market trends and future market potential in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
Fetal Heart Rate Monitoring Devices Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Device type |
|
 By Portability |
|
 By Method |
|
 By End User |
|
 By Region |
|
 Key Market Players | Bionet America Inc., Johnson & Johnson, Toshiba Corporation, CooperSurgical Inc., Drägerwerk AG & Co. KGaA, Smiths Group plc, Trismed Co. Ltd., Sunray Medical Apparatus Co. Ltd., Invacare Corporation., American HomePatient. |
Loading Table Of Content...
